Home
Browse All Titles
Sign In
Browse All Titles
Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
◀
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
▶
View All
Radioimmunoconjugates
RB
RECIST
recommended phase 2 dose (RP2D)
Answer 16.1
Drug Approval and Regulatory Issues
Question 18.1
reduced folate carrier (RFC)
refractory multiple myeloma (RRMM)
regulator of cullin 1 (Roc1)
regulatory T cells (Tregs)
response evaluation criteria in solid tumors (RECIST)
retinoblastoma (RB)
DNA Repair, Apoptotic Pathways, CDK Inhibitors
Hormonal Therapies Alone and in Combinations for Treatment of Breast Cancer
RFC
ribonucleotide reductase (RNR)
inhibition
polymorphism in thiopurine methyltransferase (TPMT)
purine analogs
R-ICE
rituximab, ifosfamide, carboplatin, etoposide (R-ICE)
Alkylating Agents
Question 2.2
RNR
Roc1
RP2D
RRMM
Refresh
first
prev
1
30
select
next
last
Displaying items 1 - 18 of 18
